MZF1-mediated GAPDH overexpression drives glycolytic reprogramming and neuroendocrine progression in advanced prostate cancer
Wang Liu, Lily He, Cuncong Zhong, Yuzhuo Wang, da zhang, Moben Mirza, Benyi Li
This study identifies MZF1-mediated GAPDH overexpression as a driver of glycolytic reprogramming and neuroendocrine progression in advanced prostate cancer, suggesting metabolic targeting as a therapeutic strategy.
Drug Resistance Updates · Aug 1, 2026Peer-reviewedCancer Biology